Laronde

Laronde's technical platform aims to develop a new type of programmable drug called Endless RNA™ (eRNA). Endless RNA™ (eRNA) is uniquely engineered RNA that can be programmed to express various proteins within the body. It is persistent and non-immunogenic, allowing for repeated dosing and offering flexibility in formulation and delivery.